|Title:||2020 consensus statement of the taiwan hypertension society and the Taiwan society of cardiology on home blood pressure monitoring for the management of arterial hypertension||Authors:||HUNG-JU LIN
|Issue Date:||2020||Publisher:||Republic of China Society of Cardiology||Journal Volume:||36||Journal Issue:||6||Start page/Pages:||537-561||Source:||Acta Cardiologica Sinica||Abstract:||
To facilitate the applications of home blood pressure (HBP)monitoring in clinical settings, the Taiwan Hypertension Society and the Taiwan Society of Cardiology jointly put forward the Consensus Statement on HBP monitoring according to up-to-date scientific evidence by convening a series of expert meetings and compiling opinions from the members of these two societies. In this Consensus Statement as well as recent international guidelines for management of arterial hypertension, HBP monitoring has been implemented in diagnostic confirmation of hypertension, identification of hypertension phenotypes, guidance of anti-hypertensive treatment, and detection of hypotensive events. HBP should be obtained by repetitivemeasurements based on the “722” principle, which is referred to duplicate blood pressure readings taken per occasion, twice daily, over seven consecutive days. The “722” principle of HBP monitoring should be applied in clinical settings, including confirmation of hypertension diagnosis, 2 weeks after adjustment of antihypertensive medications, and at least every 3 months in well-controlled hypertensive patients. A good reproducibility of HBP monitoring could be achieved by individuals carefully following the instructions before and during HBP measurement, by using validated BP devices with an upper arm cuff. Corresponding to office BP thresholds of 140/90 and 130/80 mmHg, the thresholds (or targets) of HBP are 135/85 and 130/80 mmHg, respectively. HBP-based hypertension management strategies including bedtime dosing (for uncontrolledmorning hypertension), shifting to drugs with longer-acting antihypertensive effect (for uncontrolled evening hypertension), and adding another antihypertensive drug (for uncontrolled morning and evening hypertension) should be considered. Only with the support from medical caregivers, paramedical team, or telemonitoring, HBP monitoring could reliably improve the control of hypertension. ? 2020, Republic of China Society of Cardiology. All rights reserved.
|ISSN:||1011-6842||DOI:||10.6515/ACS.202011_36(6).20201106A||SDG/Keyword:||amlodipine; angiotensin receptor antagonist; antidepressant agent; antihypertensive agent; azelnidipine; beta adrenergic receptor blocking agent; calcium channel blocking agent; dipeptidyl carboxypeptidase inhibitor; diuretic agent; doxazosin; hydrochlorothiazide; olmesartan; adult; aged; anticoagulant therapy; arm circumference; Article; atrial fibrillation; blood glucose monitoring; blood pressure; blood pressure monitoring; brain infarction; cardiovascular disease; cardiovascular mortality; cardiovascular risk; caregiver; chronic kidney failure; decision tree; diastolic blood pressure; electrocardiography; electronic health record; emotional stress; estimated glomerular filtration rate; exercise; female; food intake; health care personnel; health care system; heart failure; heart left ventricle hypertrophy; heart left ventricle mass; heart muscle revascularization; human; hypertension; hypotension; lifestyle modification; low income country; medication compliance; orthostatic hypotension; paroxysmal atrial fibrillation; perimetry; pharmacy (shop); popliteal artery; practice guideline; prescription; primary hyperaldosteronism; randomized controlled trial (topic); renin angiotensin aldosterone system; reproducibility; retinal nerve fiber layer thickness; risk assessment; risk factor; six minute walk test; subarachnoid hemorrhage; systolic blood pressure; Taiwan; telemedicine; telemonitoring; training
|Appears in Collections:||醫學系|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.